Arpita Musib;Venkata P. Palle;Manoj Kumar Khera;Ajay Soni;Punit Kumar Srivastava;Ranadheer Reddy;Sunanda G. Dastidar;Viswajanani J. Sattigeri;Sony Joseph;Manoj Kumar Tiwari;Abdul Rehman Abdul Rauf
发明人:
Viswajanani J. Sattigeri,Venkata P. Palle,Manoj Kumar Khera,Ranadheer Reddy,Manoj Kumar Tiwari,Ajay Soni,Abdul Rehman Abdul Rauf,Sony Joseph,Arpita Musib,Sunanda G. Dastidar,Punit Kumar Srivastava
申请号:
US12438182
公开号:
US08507670B2
申请日:
2007.08.21
申请国别(地区):
US
年份:
2013
代理人:
摘要:
The present invention relates to β-hydroxy and amino substituted carboxylic acids, which act as matrix metalloprotease inhibitors, particularly diastereomerically pure β-hydroxy carboxylic acids, corresponding processes for the synthesis of and pharmaceutical compositions containing the compounds of the present invention. Compounds of the present invention are useful in the treatment of various inflammatory, autoimmune and allergic diseases, such as methods of treating asthma, rheumatoid arthritis, COPD, rhinitis, osteoarthritis, psoriatic arthritis, psoriasis, pulmonary fibrosis, wound healing disorders, pulmonary inflammation, acute respiratory distress syndrome, periodontitis, multiple sclerosis, gingivitis, atherosclerosis, neointimal proliferation, which leads to restenosis and ischemic heart failure, stroke, renal diseases, tumor metastasis, and other inflammatory disorders characterized by the over-expression and over-activation of a matrix metalloproteinase using the compounds.